Cargando…
Predicting high risk of exacerbations in bronchiectasis: the E-FACED score
BACKGROUND: Although the FACED score has demonstrated a great prognostic capacity in bronchiectasis, it does not include the number or severity of exacerbations as a separate variable, which is important in the natural history of these patients. OBJECTIVE: Construction and external validation of a n...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279836/ https://www.ncbi.nlm.nih.gov/pubmed/28182132 http://dx.doi.org/10.2147/COPD.S121943 |
_version_ | 1782502854041272320 |
---|---|
author | Martinez-Garcia, MA Athanazio, RA Girón, R Máiz-Carro, L de la Rosa, D Olveira, C de Gracia, J Vendrell, M Prados-Sánchez, C Gramblicka, G Corso Pereira, M Lundgren, FL Fernandes De Figueiredo, M Arancibia, F Rached, SZ |
author_facet | Martinez-Garcia, MA Athanazio, RA Girón, R Máiz-Carro, L de la Rosa, D Olveira, C de Gracia, J Vendrell, M Prados-Sánchez, C Gramblicka, G Corso Pereira, M Lundgren, FL Fernandes De Figueiredo, M Arancibia, F Rached, SZ |
author_sort | Martinez-Garcia, MA |
collection | PubMed |
description | BACKGROUND: Although the FACED score has demonstrated a great prognostic capacity in bronchiectasis, it does not include the number or severity of exacerbations as a separate variable, which is important in the natural history of these patients. OBJECTIVE: Construction and external validation of a new index, the E-FACED, to evaluate the predictive capacity of exacerbations and mortality. METHODS: The new score was constructed on the basis of the complete cohort for the construction of the original FACED score, while the external validation was undertaken with six cohorts from three countries (Brazil, Argentina, and Chile). The main outcome was the number of annual exacerbations/hospitalizations, with all-cause and respiratory-related deaths as the secondary outcomes. A statistical evaluation comprised the relative weight and ideal cut-off point for the number or severity of the exacerbations and was incorporated into the FACED score (E-FACED). The results obtained after the application of FACED and E-FACED were compared in both the cohorts. RESULTS: A total of 1,470 patients with bronchiectasis (819 from the construction cohorts and 651 from the external validation cohorts) were followed up for 5 years after diagnosis. The best cut-off point was at least two exacerbations in the previous year (two additional points), meaning that the E-FACED has nine points of growing severity. E-FACED presented an excellent prognostic capacity for exacerbations (areas under the receiver operating characteristic curve: 0.82 for at least two exacerbations in 1 year and 0.87 for at least one hospitalization in 1 year) that was statistically better than that of the FACED score (0.72 and 0.78, P<0.05, respectively). The predictive capacities for all-cause and respiratory mortality were 0.87 and 0.86, respectively, with both being similar to those of the FACED. CONCLUSION: E-FACED score significantly increases the FACED capacity to predict future yearly exacerbations while maintaining the score’s simplicity and prognostic capacity for death. |
format | Online Article Text |
id | pubmed-5279836 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-52798362017-02-08 Predicting high risk of exacerbations in bronchiectasis: the E-FACED score Martinez-Garcia, MA Athanazio, RA Girón, R Máiz-Carro, L de la Rosa, D Olveira, C de Gracia, J Vendrell, M Prados-Sánchez, C Gramblicka, G Corso Pereira, M Lundgren, FL Fernandes De Figueiredo, M Arancibia, F Rached, SZ Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Although the FACED score has demonstrated a great prognostic capacity in bronchiectasis, it does not include the number or severity of exacerbations as a separate variable, which is important in the natural history of these patients. OBJECTIVE: Construction and external validation of a new index, the E-FACED, to evaluate the predictive capacity of exacerbations and mortality. METHODS: The new score was constructed on the basis of the complete cohort for the construction of the original FACED score, while the external validation was undertaken with six cohorts from three countries (Brazil, Argentina, and Chile). The main outcome was the number of annual exacerbations/hospitalizations, with all-cause and respiratory-related deaths as the secondary outcomes. A statistical evaluation comprised the relative weight and ideal cut-off point for the number or severity of the exacerbations and was incorporated into the FACED score (E-FACED). The results obtained after the application of FACED and E-FACED were compared in both the cohorts. RESULTS: A total of 1,470 patients with bronchiectasis (819 from the construction cohorts and 651 from the external validation cohorts) were followed up for 5 years after diagnosis. The best cut-off point was at least two exacerbations in the previous year (two additional points), meaning that the E-FACED has nine points of growing severity. E-FACED presented an excellent prognostic capacity for exacerbations (areas under the receiver operating characteristic curve: 0.82 for at least two exacerbations in 1 year and 0.87 for at least one hospitalization in 1 year) that was statistically better than that of the FACED score (0.72 and 0.78, P<0.05, respectively). The predictive capacities for all-cause and respiratory mortality were 0.87 and 0.86, respectively, with both being similar to those of the FACED. CONCLUSION: E-FACED score significantly increases the FACED capacity to predict future yearly exacerbations while maintaining the score’s simplicity and prognostic capacity for death. Dove Medical Press 2017-01-18 /pmc/articles/PMC5279836/ /pubmed/28182132 http://dx.doi.org/10.2147/COPD.S121943 Text en © 2017 Martinez-Garcia et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Martinez-Garcia, MA Athanazio, RA Girón, R Máiz-Carro, L de la Rosa, D Olveira, C de Gracia, J Vendrell, M Prados-Sánchez, C Gramblicka, G Corso Pereira, M Lundgren, FL Fernandes De Figueiredo, M Arancibia, F Rached, SZ Predicting high risk of exacerbations in bronchiectasis: the E-FACED score |
title | Predicting high risk of exacerbations in bronchiectasis: the E-FACED score |
title_full | Predicting high risk of exacerbations in bronchiectasis: the E-FACED score |
title_fullStr | Predicting high risk of exacerbations in bronchiectasis: the E-FACED score |
title_full_unstemmed | Predicting high risk of exacerbations in bronchiectasis: the E-FACED score |
title_short | Predicting high risk of exacerbations in bronchiectasis: the E-FACED score |
title_sort | predicting high risk of exacerbations in bronchiectasis: the e-faced score |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279836/ https://www.ncbi.nlm.nih.gov/pubmed/28182132 http://dx.doi.org/10.2147/COPD.S121943 |
work_keys_str_mv | AT martinezgarciama predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT athanaziora predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT gironr predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT maizcarrol predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT delarosad predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT olveirac predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT degraciaj predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT vendrellm predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT pradossanchezc predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT gramblickag predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT corsopereiram predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT lundgrenfl predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT fernandesdefigueiredom predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT arancibiaf predictinghighriskofexacerbationsinbronchiectasistheefacedscore AT rachedsz predictinghighriskofexacerbationsinbronchiectasistheefacedscore |